Skip to main content
logo
Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.010
+0.050 (5.21%)
At close: Jul 31, 2026, 4:00 PM EDT
1.003
-0.007 (-0.68%)
After-hours: Jul 31, 2026, 7:47 PM EDT

Filana Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
49-----
Market Cap Growth
-53.22%-----
Enterprise Value
-33.8900000

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-69.7069.7068.2120.0127.14

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0000.000.00
Net Debt / Equity Ratio
-1.30-1.28-0.88-0.88-0.88-0.92
Net Debt / EBITDA Ratio
1.841.010.921.162.557.21
Net Debt / FCF Ratio
2.822.911.101.472.504.45
Quick Ratio
2.062.1810.948.5328.4618.62
Current Ratio
2.082.2311.629.1329.9119.51
Return on Equity (ROE)
-61.27%-82.66%-17.19%-53.27%-31.67%-18.71%
Return on Assets (ROA)
-41.37%-69.15%-91.49%-54.83%-31.90%-18.21%
Return on Invested Capital (ROIC)
---845.41%-492.88%-337.80%-333.67%
Return on Capital Employed (ROCE)
-66.50%-86.60%-99.87%-58.02%-33.20%-18.96%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.29%-3.63%-11.14%-4.30%-2.02%-50.95%
Total Shareholder Return
-0.29%-3.63%-11.14%-4.30%-2.02%-50.95%
SEC Filings: 10-K · 10-Q